Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thyroid Cancer Metastatic × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 156 Carcinoma, Neuroendocrine 65 Thyroid Neoplasms 39 Pheochromocytoma 35 Carcinoid Tumor 35 Adrenocortical Carcinoma 35 Thyroid Carcinoma, Anaplastic 34 Thyroid Cancer, Papillary 31 Paraganglioma 27 Neoplasms 26 Adenoma, Islet Cell 24 Adenocarcinoma, Follicular 24 Somatostatinoma 23 Neoplasm Metastasis 21 Insulinoma 20 Pancreatic Neoplasms 19 Carcinoma, Medullary 19 Carcinoma, Islet Cell 19 Glucagonoma 17 Gastrinoma 17 Sarcoma 15 Pituitary Neoplasms 15 Gastro-enteropancreatic neuroendocrine tumor 15 Colorectal Neoplasms 14 Neuroblastoma 12 Multiple Endocrine Neoplasia Type 1 12 Head and Neck Neoplasms 12 Small Cell Lung Carcinoma 11 Vipoma 10 Carcinoma, Non-Small-Cell Lung 10

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡